#334 on the rich list of 14,644 insiders
Matthew Gline
CEO at Roivant Sciences; Director at Arbutus Biopharma.
$760M
in disclosed stock, +$2.6M (+0.34%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 334th of 14,644
- Companies held
- 2
- Largest holding
- ROIV, 84.0% of total
- Latest SEC filing
- Nov 12, 2026
What the $760M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Roivant Sciences ROIV Common Shares | Directly | 16,391,229 | $38.96 | $639M | 84.0% | Form 4, Nov 12, 2026 |
| Arbutus Biopharma ABUS Common Shares | Through Roivant Sciences Ltd. | 29,880,079 | $4.07 | $122M | 16.0% | Form 3, Oct 1, 2026 |
Share counts are the amounts Matthew Gline reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 331 | Bahram Akradi FOUNDER & CEO, Life Time Group Holdings. Chanhassen, MN | $773M |
| 332 | Benoit Dageville Director, Snowflake. Menlo Park, CA | $769M |
| 333 | Robert Hamilton Steers Executive Chairman, Cohen & Steers. New York, NY | $768M |
| 334 | Matthew Gline CEO, Roivant Sciences | $760M |
| 335 | Sheryl Sandberg Director, Meta Platforms. Menlo Park, CA | $757M |
| 336 | Michael Rapino President & CEO, Live Nation Entertainment. Beverly Hills, CA | $752M |
| 337 | Joseph Y. Bae Co-Chief Executive Officer, KKR & Co.. New York, NY | $750M |
Other Roivant Sciences insiders
All ROIV insiders- Dan Oren$4.01B10% owner. #78 overall
- Vivek Ramaswamy$1.83B10% owner. #153 overall
- Daniel Allen Gold$725MDirector. #279 overall
- Mayukh Sukhatme$717MPresident & CIO. #352 overall
- Frank Torti$479MPresident and Vant Chair. #475 overall
- Keith Manchester$444MDirector. #519 overall
Questions
How much stock does Matthew Gline own?
Matthew Gline holds $760,214,203 in listed stock based on SEC filings and current prices, mostly Roivant Sciences (ROIV). That ranks 334th on the Stock Rich List.
Is this Matthew Gline's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Matthew Gline last buy or sell stock?
The most recent open-market trade on file is a sale of 289,774 ROIV shares on Apr 16, 2026 at $29.16.